Total Payments
$5,534
2024 Payments
$1,390
Companies
34
Transactions
364
Medicare Patients
5,324
Medicare Billing
$852,733
Payment Breakdown by Category
Food & Beverage$5,378 (97.2%)
Education$155.98 (2.8%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,378 | 362 | 97.2% |
| Education | $155.98 | 2 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $1,340 | 121 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,172 | 64 | $0 (2024) |
| GENZYME CORPORATION | $461.94 | 26 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $422.20 | 21 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $288.75 | 20 | $0 (2024) |
| Mylan Specialty L.P. | $216.31 | 14 | $0 (2024) |
| Amgen Inc. | $207.49 | 11 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $155.98 | 2 | $0 (2024) |
| Philips Electronics North America Corporation | $144.61 | 9 | $0 (2023) |
| Genentech USA, Inc. | $131.15 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,390 | 86 | AstraZeneca Pharmaceuticals LP ($274.15) |
| 2023 | $982.96 | 62 | GlaxoSmithKline, LLC. ($267.02) |
| 2022 | $1,034 | 68 | AstraZeneca Pharmaceuticals LP ($219.57) |
| 2021 | $665.41 | 48 | GlaxoSmithKline, LLC. ($187.07) |
| 2020 | $383.37 | 21 | GENZYME CORPORATION ($110.82) |
| 2019 | $698.92 | 56 | GlaxoSmithKline, LLC. ($223.90) |
| 2018 | $254.06 | 22 | GlaxoSmithKline, LLC. ($130.45) |
| 2017 | $124.99 | 1 | AstraZeneca Pharmaceuticals LP ($124.99) |
All Payment Transactions
364 individual payment records from CMS Open Payments — Page 1 of 15
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/16/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $7.53 | General |
| Category: IMMUNOLOGY | ||||||
| 12/13/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Immunology | ||||||
| 12/12/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: RESPIRATORY | ||||||
| 12/09/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.86 | General |
| Category: Immunology | ||||||
| 12/02/2024 | Takeda Pharmaceuticals U.S.A., Inc. | ARALAST (Biological) | Food and Beverage | In-kind items and services | $28.33 | General |
| Category: IMMUNOLOGY | ||||||
| 11/26/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug), UPTRAVI | Food and Beverage | In-kind items and services | $15.88 | General |
| Category: Cardiology | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $15.27 | General |
| Category: Respiratory | ||||||
| 11/15/2024 | Genentech USA, Inc. | Xolair (Biological) | Food and Beverage | In-kind items and services | $18.62 | General |
| Category: Immunology | ||||||
| 11/11/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $9.73 | General |
| Category: RESPIRATORY | ||||||
| 11/07/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 10/29/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 10/28/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $6.85 | General |
| Category: Immunology | ||||||
| 10/24/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $19.16 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/19/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: RESPIRATORY | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Respiratory | ||||||
| 10/15/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $17.98 | General |
| Category: Respiratory | ||||||
| 10/04/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $17.05 | General |
| Category: Immunology | ||||||
| 10/03/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.14 | General |
| Category: Immunology | ||||||
| 09/27/2024 | JAZZ PHARMACEUTICALS INC. | XYWAV (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: NEUROLOGY | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | FASENRA (Biological) | Food and Beverage | In-kind items and services | $19.32 | General |
| Category: Respiratory | ||||||
| 09/19/2024 | Electromed, Inc. | SMARTVEST (Device) | Food and Beverage | Cash or cash equivalent | $17.79 | General |
| Category: HFCWO | ||||||
| 09/16/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.34 | General |
| Category: Immunology | ||||||
| 09/12/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.65 | General |
| Category: Immunology | ||||||
| 09/12/2024 | GlaxoSmithKline, LLC. | NUCALA (Biological) | Food and Beverage | In-kind items and services | $4.66 | General |
| Category: IMMUNOLOGY | ||||||
| 09/11/2024 | AstraZeneca Pharmaceuticals LP | TEZSPIRE (Biological) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Respiratory | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,282 | 2,012 | $566,238 | $197,558 |
| 2022 | 14 | 1,384 | 2,146 | $593,663 | $210,716 |
| 2021 | 13 | 1,334 | 2,105 | $594,754 | $215,740 |
| 2020 | 14 | 1,324 | 2,223 | $410,891 | $228,720 |
Total Patients
5,324
Total Services
8,486
Medicare Billing
$852,733
Procedure Codes
55
All Medicare Procedures & Services
55 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 370 | 558 | $158,472 | $56,459 | 35.6% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2023 | 99 | 231 | $137,676 | $41,855 | 30.4% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 151 | 332 | $81,116 | $33,695 | 41.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 204 | 429 | $69,667 | $28,505 | 40.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 130 | 132 | $56,760 | $19,080 | 33.6% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2023 | 79 | 80 | $14,800 | $3,970 | 26.8% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 27 | 27 | $9,855 | $3,896 | 39.5% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 32 | 32 | $9,312 | $3,551 | 38.1% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2023 | 76 | 76 | $11,020 | $2,922 | 26.5% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2023 | 67 | 68 | $8,160 | $1,594 | 19.5% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2023 | 33 | 33 | $6,600 | $1,106 | 16.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 14 | 14 | $2,800 | $924.72 | 33.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 363 | 515 | $146,331 | $53,776 | 36.7% |
| 99291 | Critical care, first 30-74 minutes | Facility | 2022 | 98 | 241 | $143,636 | $44,748 | 31.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 200 | 370 | $81,770 | $32,114 | 39.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 221 | 510 | $79,050 | $30,613 | 38.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 133 | 135 | $58,050 | $22,626 | 39.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 48 | 48 | $17,340 | $6,350 | 36.6% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 52 | 54 | $15,714 | $5,918 | 37.7% |
| 94729 | Test to examine how well the lungs exchange gases | Office | 2022 | 74 | 74 | $13,534 | $3,862 | 28.5% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 19 | 23 | $9,085 | $3,474 | 38.2% |
| 94727 | Test to determine lung volumes using gas dilution or washout | Office | 2022 | 69 | 69 | $9,900 | $2,705 | 27.3% |
| 94060 | Test to measure expiratory airflow and volume changes before and after medication administration | Office | 2022 | 39 | 39 | $7,800 | $1,389 | 17.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 14 | 14 | $3,206 | $1,266 | 39.5% |
| 94010 | Test to measure expiratory airflow and volume | Office | 2022 | 42 | 42 | $4,947 | $1,007 | 20.3% |
About Dr. Nicholas Roy, D.O
Dr. Nicholas Roy, D.O is a Pulmonary Disease healthcare provider based in Cherry Hill, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/30/2010. The National Provider Identifier (NPI) number assigned to this provider is 1619288073.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Nicholas Roy, D.O has received a total of $5,534 in payments from pharmaceutical and medical device companies, with $1,390 received in 2024. These payments were reported across 364 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($5,378).
As a Medicare-enrolled provider, Roy has provided services to 5,324 Medicare beneficiaries, totaling 8,486 services with total Medicare billing of $852,733. Data is available for 4 years (2020–2023), covering 55 distinct procedure/service records.
Ad
Practice Information
- Specialty Pulmonary Disease
- Other Specialties Critical Care Medicine
- Location Cherry Hill, NJ
- Active Since 06/30/2010
- Last Updated 12/29/2023
- Taxonomy Code 207RP1001X
- Entity Type Individual
- NPI Number 1619288073
Products in Payments
- DUPIXENT (Biological) $997.64
- TRELEGY ELLIPTA (Drug) $598.45
- NUCALA (Biological) $396.73
- TEZSPIRE (Biological) $366.66
- BREZTRI (Drug) $323.20
- STIOLTO RESPIMAT (Drug) $212.81
- SYMBICORT (Drug) $182.91
- FASENRA (Biological) $150.79
- ANORO (Drug) $145.33
- BEVESPI AEROSPHERE (Drug) $137.99
- ANORO ELLIPTA (Drug) $122.52
- Xolair (Biological) $115.36
- Yupelri (Drug) $115.14
- SMARTVEST (Device) $112.05
- Prolastin-C Liquid (Biological) $108.16
- AIRSUPRA (Drug) $106.66
- YUPELRI (Drug) $101.17
- Arikayce (Drug) $99.87
- (8874) inCourage (Device) $89.51
- ARALAST (Biological) $77.50
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Pulmonary Disease Doctors in Cherry Hill
Dr. Steven Baumgarten, M.d, M.D
Pulmonary Disease — Payments: $9,230
Pulmonary Disease $9,230
Ira Horowitz, M.d, M.D
Pulmonary Disease — Payments: $7,417
Pulmonary Disease $7,417
Dr. David Baumgarten, Md, MD
Pulmonary Disease — Payments: $4,680
Pulmonary Disease $4,680
Steffi Lena, D.o, D.O
Pulmonary Disease — Payments: $1,829
Pulmonary Disease $1,829
Dr. Alan Pope, M.d, M.D
Pulmonary Disease — Payments: $1,164
Pulmonary Disease $1,164
Dipakkumar Malli, Md, MD
Pulmonary Disease — Payments: $134.02
Pulmonary Disease $134.02